Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
7
NMPA:7
Drug Approvals
Ambroxol Hydrochloride and Clenbuterol Hydrochloride Oral Solution
- Product Name
- 氨溴特罗口服溶液
- Approval Number
- 国药准字H20249679
- Approval Date
- Dec 6, 2024
NMPA
Ambroxol Hydrochloride and Clenbuterol Hydrochloride Oral Solution
- Product Name
- 氨溴特罗口服溶液
- Approval Number
- 国药准字H20249548
- Approval Date
- Dec 1, 2024
NMPA
Metaraminol Bitartrate Injection
- Product Name
- 重酒石酸间羟胺注射液
- Approval Number
- 国药准字H20243875
- Approval Date
- Jun 4, 2024
NMPA
Magnesium Sulfate Injection
- Product Name
- 硫酸镁注射液
- Approval Number
- 国药准字H20243251
- Approval Date
- Feb 23, 2024
NMPA
Magnesium Sulfate Injection
- Product Name
- 硫酸镁注射液
- Approval Number
- 国药准字H20243252
- Approval Date
- Feb 23, 2024
NMPA
Cetrorelix Acetate for Injection
- Product Name
- 注射用醋酸西曲瑞克
- Approval Number
- 国药准字H20233630
- Approval Date
- May 29, 2023
NMPA
Somatostatin for Injection
- Product Name
- 注射用生长抑素
- Approval Number
- 国药准字H20223138
- Approval Date
- Mar 16, 2022
NMPA
Clinical Trials
No trials found
News
No news found